Results
269
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
269 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
FEAT | ₪1.43 | -10.3% | 9.7% | ₪6.1m | n/a | PE85.4x | n/a | n/a | Diversified Financials | ||
ESLT | ₪1,079.90 | 0.3% | 44.0% | ₪49.0b | n/a | PE51.5x | E20.2% | 0.7% | Capital Goods | ||
RLCO | ₪51.22 | -4.1% | 64.8% | ₪202.2m | n/a | PE6x | n/a | 13.2% | Retail | ||
ILX | ₪74.65 | 1.4% | 22.6% | ₪838.2m | n/a | PE15.4x | n/a | 1.8% | Healthcare | ||
ANLT | ₪69.75 | 0.6% | 105.8% | ₪814.5m | n/a | PE17.9x | n/a | 1.4% | Diversified Financials | ||
EMITF-M | ₪7.40 | -8.2% | 84.5% | ₪79.4m | n/a | PS240.1x | n/a | 10.1% | Healthcare | ||
LUMI | ₪44.85 | -0.3% | 63.4% | ₪67.5b | ₪47.75 | PB1.1x | S0.08% | 2.5% | Banks | ||
KMDA | ₪24.35 | -5.9% | 16.0% | ₪1.4b | n/a | PE24.9x | E20.4% | n/a | Pharmaceuticals & Biotech | ||
ORAD | ₪0.63 | 2.1% | 18.0% | ₪56.1m | n/a | PE8.6x | n/a | n/a | Tech | ||
PAYT | ₪72.38 | 3.8% | 51.5% | ₪562.3m | n/a | PE15.6x | n/a | 4.7% | Capital Goods | ||
FORTY | ₪329.50 | 6.2% | 35.7% | ₪4.9b | n/a | PE18.7x | n/a | 1.4% | Software | ||
AMRK | ₪29.35 | -1.7% | 48.4% | ₪368.5m | n/a | PE9.3x | n/a | 3.4% | Capital Goods | ||
SLCL | ₪5.35 | 0.4% | -17.5% | ₪19.1m | n/a | PS5.7x | n/a | n/a | Healthcare | ||
MNIN | ₪14.00 | -5.3% | 75.6% | ₪551.9m | n/a | PE13.9x | n/a | 2.3% | Capital Goods | ||
SNEL | ₪18.28 | 11.3% | 0.2% | ₪101.5m | n/a | PE10.9x | n/a | 15.5% | Software | ||
QLRD | ₪31.78 | -6.8% | 19.7% | ₪115.5m | n/a | PS4.7x | n/a | n/a | Software | ||
EPIT | ₪9.28 | 6.2% | 149.8% | ₪273.4m | n/a | PE28.8x | n/a | n/a | Healthcare | ||
RIMO | ₪51.07 | -3.6% | 1.3% | ₪431.9m | n/a | PE10.4x | n/a | 5.8% | Materials | ||
AVRT | ₪0.47 | -1.5% | -20.7% | ₪163.9m | n/a | PS1.2x | n/a | n/a | Commercial Services | ||
AVIA | ₪17.48 | 2.3% | 43.5% | ₪133.8m | n/a | PE14.6x | n/a | 9.7% | Consumer Services | ||
SMAG | ₪3.56 | 0% | -29.2% | ₪14.9m | n/a | PB0.4x | n/a | n/a | Pharmaceuticals & Biotech | ||
RSEL | ₪11.13 | -1.9% | 65.6% | ₪113.5m | n/a | PE31.9x | n/a | 4.4% | Capital Goods | ||
ORBI | ₪30.96 | -0.5% | 17.7% | ₪779.9m | n/a | PE20.4x | n/a | 12.4% | Capital Goods | ||
CMDR | ₪357.30 | -1.1% | 40.9% | ₪1.2b | n/a | PE15.1x | n/a | 4.9% | Software |